Log in
Enquire now

List of Mankind Pharma Ltd patents

List of Mankind Pharma Ltd patents
List of Brigham Young University patents
List of Anvik Corporation patents
List of Ra Pharmaceuticals patents
CEOs of ballet companies
List of companies in First Analysis's investment portfolio
Patents where
Current Assignee
Name
is
Mankind Pharma LtdMankind Pharma Ltd
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11382866 Fixed dose pharmaceutical composition of valsartan and sacubitril

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11382866
July 12, 2022
‌
US Patent 11318183 Stable pharmaceutical composition of vasopressin

Patent 11318183 was granted and assigned to Mankind Pharma Ltd on May, 2022 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11318183
May 3, 2022
‌
US Patent 10208030 GPR119 agonist compounds

Patent 10208030 was granted and assigned to Mankind Pharma Ltd on February, 2019 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10208030
February 19, 2019
‌
US Patent 10954229 GPR119 agonist compounds

Patent 10954229 was granted and assigned to Mankind Pharma Ltd on March, 2021 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10954229
March 23, 2021
‌
US Patent 10919915 Compounds as GPR119 agonists

Patent 10919915 was granted and assigned to Mankind Pharma Ltd on February, 2021 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10919915
February 16, 2021
‌
US Patent 11246862 Process for the preparation of lifitegrast

Patent 11246862 was granted and assigned to Mankind Pharma Ltd on February, 2022 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11246862
February 15, 2022
‌
US Patent 10377710 Process for the preparation of considerably pure Silodosin

Patent 10377710 was granted and assigned to Mankind Pharma Ltd on August, 2019 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10377710
August 13, 2019
‌
US Patent 10239833 Intermediates, their process and use in preparation of selective α1-adrenoceptor antagonists, Silodosin

Patent 10239833 was granted and assigned to Mankind Pharma Ltd on March, 2019 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10239833
March 26, 2019
‌
US Patent 10167271 Fluoroquinolone carboxylic acid compounds and use thereof for the preparation of besifloxacin hydrochloride

Patent 10167271 was granted and assigned to Mankind Pharma Ltd on January, 2019 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10167271
January 1, 2019
‌
US Patent 10752622 GPR119 agonist compounds

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10752622
August 25, 2020
‌
US Patent 10526345 Compounds as GPR119 agonists

Patent 10526345 was granted and assigned to Mankind Pharma Ltd on January, 2020 by the United States Patent and Trademark Office.

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
10526345
January 7, 2020
‌
US Patent 11707502 Stable pharmaceutical composition of vasopressin

Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
Mankind Pharma Ltd
United States Patent and Trademark Office
United States Patent and Trademark Office
11707502
July 25, 2023
12 results
0 selected
12 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us